about
From numbers to a biological sense: How the strategy chosen for metabolomics data treatment may affect final results. A practical example based on urine fingerprints obtained by LC-MS.Missing value imputation strategies for metabolomics data.Metabolomic approach with LC-QTOF to study the effect of a nutraceutical treatment on urine of diabetic rats.Differentiating signals to make biological sense - A guide through databases for MS-based non-targeted metabolomics.CE-MS-based serum fingerprinting to track evolution of type 2 diabetes mellitus.Capillary electrophoresis mass spectrometry as a tool for untargeted metabolomics.A Single In-Vial Dual Extraction Strategy for the Simultaneous Lipidomics and Proteomics Analysis of HDL and LDL Fractions.Rapid and Reliable Identification of Phospholipids for Untargeted Metabolomics with LC-ESI-QTOF-MS/MS.A complex interplay between sphingolipid and sterol metabolism revealed by perturbations to the Leishmania metabolome caused by miltefosine."Gear mechanism" of bariatric interventions revealed by untargeted metabolomics.In-source fragmentation and correlation analysis as tools for metabolite identification exemplified with CE-TOF untargeted metabolomics.Serum metabolic fingerprinting after exposure of rats to quinolinic acid.Metabolic Clustering Analysis as a Strategy for Compound Selection in the Drug Discovery Pipeline for Leishmaniasis.Characterization and annotation of oxidized glycerophosphocholines for non-targeted metabolomics with LC-QTOF-MS dataFlow Cytometry Has a Significant Impact on the Cellular MetabolomeIn-vial dual extraction liquid chromatography coupled to mass spectrometry applied to streptozotocin-treated diabetic rats. Tips and pitfalls of the methodCombination of LC–MS- and GC–MS-based Metabolomics to Study the Effect of Ozonated Autohemotherapy on Human BloodIn-Vial Dual Extraction for Direct LC-MS Analysis of Plasma for Comprehensive and Highly Reproducible Metabolic FingerprintingThe Type 2 Diabetes Susceptibility PROX1 Gene Variants Are Associated with Postprandial Plasma Metabolites Profile in Non-Diabetic Men.Knowledge-based metabolite annotation tool: CEU Mass MediatorCEU Mass Mediator 3.0: A Metabolite Annotation ToolMetabolomics Reveal Altered Postprandial Lipid Metabolism After a High-Carbohydrate Meal in Men at High Genetic Risk of DiabetesOxidized glycerophosphatidylcholines in diabetes through non-targeted metabolomics: Their annotation and biological meaningCapillary Electrophoresis Mass Spectrometry as a Tool for Untargeted Metabolomics
P50
Q30649914-D44F934C-C7EC-4F8C-A00D-94C672E8FE5DQ30993852-9D168B23-EF3E-4FAA-A5DD-A443DD3EE878Q33750625-D9928892-62E8-4BDC-93CA-E65A28CE4933Q38377751-870C9475-801B-4FAA-A748-76956D229677Q39008206-0EC33472-A4A5-4F10-BF9B-B8B8AB94BD5BQ39030357-8B915003-6278-45F9-8AD7-5D43BF6B14DAQ39819161-A9BC3E8D-1860-46C0-BE0A-A35B1E1EEAADQ40829944-5D7723C5-FC1F-4DDC-A12A-50B2CC14376AQ49792065-A9017E6F-FD94-4BA2-B903-DBFB2A6DDD4AQ50056113-285F1FA7-3F75-404D-B5EF-2229DADFCF74Q51000477-322AC309-B3B6-4BE1-BFF4-3E6E6DB89BF9Q51172293-6CA5500F-DB89-44C1-A973-8839D50A83C0Q52578507-95CA7DA4-CBEF-41C7-80D2-C60DBD257811Q57181052-2C0410F4-F269-4A8A-A372-20D34E28A6F5Q58617190-C2D86CE9-8D69-4FB0-9E22-923E45D7B784Q59622189-915935AC-7972-4481-ACB0-5EEF22B20A5BQ59622204-956BF14D-3629-4556-99AD-509D3BCB1DAAQ59622206-8AA2E925-CC9C-4BC6-A6E9-F05AF2E02FC0Q64910805-4DD76AE2-A44D-4CFF-80C1-CFF6E5C5F9BDQ88081147-16880ED9-A1F1-462C-B113-6CE5A2C72D48Q90687773-A1C1FD7C-BC80-4A88-BD58-B29CEC18621FQ91719458-508CA71D-4E4F-49CA-A125-9812D9F68A65Q91886941-E82DBD5B-F65E-42D0-AFC5-8947B75B3D2CQ92233371-828B2168-851E-45B1-A9C4-03199A7CB38C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joanna Godzien
@ast
Joanna Godzien
@en
Joanna Godzien
@es
Joanna Godzien
@nl
type
label
Joanna Godzien
@ast
Joanna Godzien
@en
Joanna Godzien
@es
Joanna Godzien
@nl
prefLabel
Joanna Godzien
@ast
Joanna Godzien
@en
Joanna Godzien
@es
Joanna Godzien
@nl
P106
P31
P496
0000-0002-9477-057X